Proteomics, biomarkers, and HIV-1: A current perspective

Maire Rose Donnelly, Pawel S Ciborowski

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Despite more than three decades of extensive research, HIV-1 infection although well controlled with cART, remains incurable. Multifactorial complexity of the viral life-cycle poses great challenges in understanding molecular mechanisms underlying this infection and the development of biomarkers, which we hope will lead us to its eradication. For a more in-depth understanding of how the virus interacts with host target cells, T cells and macrophages, proteomic profiling techniques that offer strategies to investigate the proteome in its entirety were employed. Here, we review proteomic studies related to HIV-1 infection and discuss perspectives and limitations of proteomic and systems biology approaches in future studies.

Original languageEnglish (US)
Pages (from-to)110-125
Number of pages16
JournalProteomics - Clinical Applications
Volume10
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Biomarkers
Proteomics
HIV-1
HIV Infections
Systems Biology
T-cells
Macrophages
Proteome
Life Cycle Stages
Viruses
Life cycle
T-Lymphocytes
Infection
Research

Keywords

  • Biomarker
  • Body fluids
  • HIV
  • Macrophage
  • Systems biology
  • T cell

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Proteomics, biomarkers, and HIV-1 : A current perspective. / Donnelly, Maire Rose; Ciborowski, Pawel S.

In: Proteomics - Clinical Applications, Vol. 10, No. 2, 01.02.2016, p. 110-125.

Research output: Contribution to journalArticle

@article{e1d5c02612b84e7aadd9421145acd6d3,
title = "Proteomics, biomarkers, and HIV-1: A current perspective",
abstract = "Despite more than three decades of extensive research, HIV-1 infection although well controlled with cART, remains incurable. Multifactorial complexity of the viral life-cycle poses great challenges in understanding molecular mechanisms underlying this infection and the development of biomarkers, which we hope will lead us to its eradication. For a more in-depth understanding of how the virus interacts with host target cells, T cells and macrophages, proteomic profiling techniques that offer strategies to investigate the proteome in its entirety were employed. Here, we review proteomic studies related to HIV-1 infection and discuss perspectives and limitations of proteomic and systems biology approaches in future studies.",
keywords = "Biomarker, Body fluids, HIV, Macrophage, Systems biology, T cell",
author = "Donnelly, {Maire Rose} and Ciborowski, {Pawel S}",
year = "2016",
month = "2",
day = "1",
doi = "10.1002/prca.201500002",
language = "English (US)",
volume = "10",
pages = "110--125",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
publisher = "Wiley-VCH Verlag",
number = "2",

}

TY - JOUR

T1 - Proteomics, biomarkers, and HIV-1

T2 - A current perspective

AU - Donnelly, Maire Rose

AU - Ciborowski, Pawel S

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Despite more than three decades of extensive research, HIV-1 infection although well controlled with cART, remains incurable. Multifactorial complexity of the viral life-cycle poses great challenges in understanding molecular mechanisms underlying this infection and the development of biomarkers, which we hope will lead us to its eradication. For a more in-depth understanding of how the virus interacts with host target cells, T cells and macrophages, proteomic profiling techniques that offer strategies to investigate the proteome in its entirety were employed. Here, we review proteomic studies related to HIV-1 infection and discuss perspectives and limitations of proteomic and systems biology approaches in future studies.

AB - Despite more than three decades of extensive research, HIV-1 infection although well controlled with cART, remains incurable. Multifactorial complexity of the viral life-cycle poses great challenges in understanding molecular mechanisms underlying this infection and the development of biomarkers, which we hope will lead us to its eradication. For a more in-depth understanding of how the virus interacts with host target cells, T cells and macrophages, proteomic profiling techniques that offer strategies to investigate the proteome in its entirety were employed. Here, we review proteomic studies related to HIV-1 infection and discuss perspectives and limitations of proteomic and systems biology approaches in future studies.

KW - Biomarker

KW - Body fluids

KW - HIV

KW - Macrophage

KW - Systems biology

KW - T cell

UR - http://www.scopus.com/inward/record.url?scp=84956789227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956789227&partnerID=8YFLogxK

U2 - 10.1002/prca.201500002

DO - 10.1002/prca.201500002

M3 - Article

C2 - 26033875

AN - SCOPUS:84956789227

VL - 10

SP - 110

EP - 125

JO - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 2

ER -